Furthermore, in 80 HCC patients, Stard5 expression was scored as moderately positive in 25%, while 36.25% were strongly positive, compared to 28.75% moderately positive and 52.5% strongly positive in adjacent normal liver tissue (Fig. 7b, c). The gene discussed is STARD5; the disease is hepatocellular carcinoma.